James P. Madigan
0000-0002-0503-3704
Publication & Citation Trends
Publications
0 total
Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions OA
Cited by 5
Semantic Scholar
Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model OA
Cited by 7
Semantic Scholar
Single-Cell ATAC and Single-Nucleus RNA Sequencing Uncovers Cellular Heterogeneity Within Pancreatic Neuroendocrine Tumors
Cited by 0
Semantic Scholar
Multiple Layers of Epigenetic Regulation Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine Tumors
Cited by 0
Semantic Scholar
Upregulation of Somatostatin Receptor Type 2 in a Receptor-Deficient In Vivo Pancreatic Neuroendocrine Tumor Model Improves Tumor Response to Targeted 177Lu-DOTATATE OA
Cited by 3
Semantic Scholar
A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer. OA
Cited by 31
Semantic Scholar
Correction: Inhibition of glutathione peroxidase mediates the collateral sensitivity of multidrug-resistant cells to tiopronin. OA
Cited by 1
Semantic Scholar
Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities OA
Cited by 13
Semantic Scholar
Research Topics
Neuroendocrine Tumor Research Advances
(35)
Lung Cancer Research Studies
(30)
Neuroblastoma Research and Treatments
(19)
Protein Kinase Regulation and GTPase Signaling
(9)
Drug Transport and Resistance Mechanisms
(8)
Affiliations
University of North Carolina at Chapel Hill
New York State Department of Environmental Conservation
New York State Department of Health
National Institutes of Health
The Royal Melbourne Hospital